ישראל - עברית - Ministry of Health

eisai israel ltd., israel - perampanel as anhydrous - תרחיף - perampanel as anhydrous 0.5 mg / 1 ml - perampanel

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - terbutaline sulfate - אבקה לשאיפה - terbutaline sulfate 0.5 mg/dose - terbutaline - terbutaline - for the relief of bronchospasm in patients with reversible onbstructive airway disease, including asthma, chronic bronchitis and emphysema.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

ישראל - עברית - Ministry of Health

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ג'ל - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - betamethasone - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

ישראל - עברית - Ministry of Health

eisai israel ltd., israel - perampanel as anhydrous - טבליות מצופות פילם - perampanel as anhydrous 2 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.

ישראל - עברית - Ministry of Health

eisai israel ltd., israel - perampanel as anhydrous - טבליות מצופות פילם - perampanel as anhydrous 4 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.